雞熱休克70 之DNA 異種疫苗可抑制犬腫瘤生長
WY Yu - 臺灣大學獸醫學研究所學位論文, 2010 - airitilibrary.com
Immunization with xenogeneic DNA is a promising cancer treatment, as it generates
autoantibodies and cytotoxic T cells to break the tumor tolerance against self-antigens. Heat …
autoantibodies and cytotoxic T cells to break the tumor tolerance against self-antigens. Heat …
雞熱休克70 之DNA 異種疫苗可抑制犬腫瘤生長
游文瑛 - 2010 - tdr.lib.ntu.edu.tw
接種異種動物之去氧核醣核酸(xenogeneic DNA) 被認為是一種有效治療腫瘤的方式,
此種疫苗可使免疫系統針對表現於腫瘤之自我抗原, 產生特異性抗體及毒殺型T 細胞 …
此種疫苗可使免疫系統針對表現於腫瘤之自我抗原, 產生特異性抗體及毒殺型T 細胞 …
Chicken HSP70 DNA xenogeneic vaccine inhibits tumor growth in a canine cancer model (131.8)
WY Yu, TF Chuang, L Fischer… - The Journal of Immunology, 2010 - journals.aai.org
Immunization with xenogeneic DNA is a promising cancer treatment, as it generates immune
responses to break tumor tolerance to self-antigens. Heat shock protein 70 (HSP70) is …
responses to break tumor tolerance to self-antigens. Heat shock protein 70 (HSP70) is …
Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model
WY Yu, TF Chuang, C Guichard, H El-Garch, D Tierny… - Vaccine, 2011 - Elsevier
Immunization with xenogeneic DNA is a promising cancer treatment to overcome tolerance
to self-antigens. Heat shock protein 70 (HSP70) is over-expressed in various kinds of tumors …
to self-antigens. Heat shock protein 70 (HSP70) is over-expressed in various kinds of tumors …
Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model.
YWY Yu WenYing, CTF Chuang TienFu, C Guichard… - 2011 - cabidigitallibrary.org
Immunization with xenogeneic DNA is a promising cancer treatment to overcome tolerance
to self-antigens. Heat shock protein 70 (HSP70) is over-expressed in various kinds of tumors …
to self-antigens. Heat shock protein 70 (HSP70) is over-expressed in various kinds of tumors …
[PDF][PDF] Pilot study of p62 DNA vaccine in dogs with mammary tumors
CV Mariotti, G Catone, MY Sherman, A Concetti… - researchgate.net
Our previous data demonstrated profound anti-tumor and anti-metastatic effects of p62
(sqstm1) DNA vaccine in rodents with various types of transplantable tumors. Testing anti …
(sqstm1) DNA vaccine in rodents with various types of transplantable tumors. Testing anti …
[HTML][HTML] Pilot study of p62 DNA vaccine in dogs with mammary tumors
V Gabai, FM Venanzi, E Bagashova, O Rud, F Mariotti… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Our previous data demonstrated profound anti-tumor and anti-metastatic effects of p62
(sqstm1) DNA vaccine in rodents with various types of transplantable tumors. Testing anti …
(sqstm1) DNA vaccine in rodents with various types of transplantable tumors. Testing anti …
Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy
Y Li, J Subjeck, G Yang, E Repasky, XY Wang - Vaccine, 2006 - Elsevier
In this study, we explored the protective anti-tumor potency of mouse (self) Hsp70 or Hsp110-
based DNA vaccination approach targeting a tumor-associated antigen, human papilloma …
based DNA vaccination approach targeting a tumor-associated antigen, human papilloma …
Pilot study of p62 DNA vaccine in dogs with mammary tumors
V Gabai, F Venanzi, E Bagashova, O Rud, F Mariotti… - ONCOTARGET, 2014 - iris.unime.it
Our previous data demonstrated profound anti-tumor and anti-metastatic effects of p62
(sqstm1) DNA vaccine in rodents with various types of transplantable tumors. Testing anti …
(sqstm1) DNA vaccine in rodents with various types of transplantable tumors. Testing anti …
RNA‐transfected CD40‐activated B cells as a vaccine strategy in canine malignancies
B Overley, CM Coughlin, MS Leibowitz… - Veterinary and …, 2004 - Wiley Online Library
Introduction: Cell‐based vaccine strategies using dendritic cells as cellular adjuvant have
entered phase III trials in humans and have been found to be safe, feasible, and potentially …
entered phase III trials in humans and have been found to be safe, feasible, and potentially …